These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 16797858)

  • 1. Application of beta-lactamase-dependent prodrugs in clostridial-directed enzyme therapy (CDEPT): a proposal.
    Tirandaz H; Hamedi J; Marashi SA
    Med Hypotheses; 2006; 67(4):998-9. PubMed ID: 16797858
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypoxia in malignant tumors the target for clostridial therapeutic gene strategies].
    Wallner G; Misiuna P; Cygan W; Cygan Z
    Pol Merkur Lekarski; 2005 Aug; 19(110):242-4. PubMed ID: 16245444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridia in cancer therapy.
    Minton NP
    Nat Rev Microbiol; 2003 Dec; 1(3):237-42. PubMed ID: 15035028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genes in the service of therapeutic index: progress for virus-directed enzyme prodrug therapy.
    Sausville EA
    J Clin Oncol; 2004 May; 22(9):1535-7. PubMed ID: 15051753
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapeutic tumour targeting using clostridial spores.
    Minton NP; Mauchline ML; Lemmon MJ; Brehm JK; Fox M; Michael NP; Giaccia A; Brown JM
    FEMS Microbiol Rev; 1995 Oct; 17(3):357-64. PubMed ID: 7576773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-directed enzyme prodrug therapy: a current assessment.
    McKeown SR; Ward C; Robson T
    Curr Opin Mol Ther; 2004 Aug; 6(4):421-35. PubMed ID: 15468601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Image-guided enzyme/prodrug cancer therapy.
    Li C; Penet MF; Winnard P; Artemov D; Bhujwalla ZM
    Clin Cancer Res; 2008 Jan; 14(2):515-22. PubMed ID: 18223227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genus Bifidobacterium for cancer gene therapy.
    Fujimori M; Amano J; Taniguchi S
    Curr Opin Drug Discov Devel; 2002 Mar; 5(2):200-3. PubMed ID: 11926126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of a beta-lactamase-Fab' conjugate for the site-specific activation of oncolytic agents.
    Meyer DL; Jungheim LN; Mikolajczyk SD; Shepherd TA; Starling JJ; Ahlem CN
    Bioconjug Chem; 1992; 3(1):42-8. PubMed ID: 1616948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal formulation of 5-fluorocytosine in suicide gene therapy with cytosine deaminase--for colorectal cancer.
    Chaszczewska-Markowska M; Stebelska K; Sikorski A; Madej J; Opolski A; Ugorski M
    Cancer Lett; 2008 Apr; 262(2):164-72. PubMed ID: 18291575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular therapy for cancer.
    Deisseroth A; Guo D; Wang T; Fujii T; Fu SQ; Cote R; Savinov S; Liu F; Loewe R; Pizzorno G; Austin D; Crystal R; Chung I
    Cancer J Sci Am; 1998 May; 4 Suppl 1():S5-7. PubMed ID: 9619264
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytochrome P450 reductase dependent inhibition of cytochrome P450 2B1 activity: Implications for gene directed enzyme prodrug therapy.
    Lengler J; Omann M; Düvier D; Holzmüller H; Gregor W; Salmons B; Günzburg WH; Renner M
    Biochem Pharmacol; 2006 Sep; 72(7):893-901. PubMed ID: 16887103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
    You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations.
    Zhao WH; Hu ZQ; Chen G; Ito R; Shimamura T
    Chemotherapy; 2008; 54(1):31-7. PubMed ID: 18063864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia response element-driven cytosine deaminase/5-fluorocytosine gene therapy system: a highly effective approach to overcome the dynamics of tumour hypoxia and enhance the radiosensitivity of prostate cancer cells in vitro.
    Marignol L; Foley R; Southgate TD; Coffey M; Hollywood D; Lawler M
    J Gene Med; 2009 Feb; 11(2):169-79. PubMed ID: 19051213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suicide gene therapy with the yeast fusion gene cytosine deaminase/uracil phosphoribosyltransferase is not enough for pancreatic cancer.
    Fogar P; Navaglia F; Basso D; Greco E; Zambon CF; Fadi E; Falda A; Stranges A; Vannozzi F; Danesi R; Pedrazzoli S; Plebani M
    Pancreas; 2007 Oct; 35(3):224-31. PubMed ID: 17895842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-spectrum-beta-lactamase-producing Enterobacteriaceae strains in various types of private health care centers.
    Arpin C; Coulange L; Dubois V; André C; Fischer I; Fourmaux S; Grobost F; Jullin J; Dutilh B; Couture JF; Noury P; Lagrange I; Ducastaing A; Doermann HP; Quentin C
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3440-4. PubMed ID: 17591853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-lactamase reporter system for selecting high-producing yeast clones.
    Hribar G; Smilović V; Zupan AL; Gaberc-Porekar V
    Biotechniques; 2008 Apr; 44(4):477-8, 480, 482 passim. PubMed ID: 18476812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuated Salmonella targets prodrug activating enzyme carboxypeptidase G2 to mouse melanoma and human breast and colon carcinomas for effective suicide gene therapy.
    Friedlos F; Lehouritis P; Ogilvie L; Hedley D; Davies L; Bermudes D; King I; Martin J; Marais R; Springer CJ
    Clin Cancer Res; 2008 Jul; 14(13):4259-66. PubMed ID: 18594008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of beta-lactamase activated nitric oxide donors.
    Tang X; Cai T; Wang PG
    Bioorg Med Chem Lett; 2003 May; 13(10):1687-90. PubMed ID: 12729642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.